id | C00023672 |
---|---|
Name | Wortmannin |
CAS RN | 19545-26-7 |
Standard InChI | InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3 |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 4941 |
By standard InChI | CHEMBL428496 |
---|---|
By standard InChI Main Layer | CHEMBL428496 CHEMBL295038 CHEMBL1418590 CHEMBL1474372 |
By LinkDB | C15181 |
---|
By CAS RN | C009687 |
---|
class name | count |
---|
family name | count |
---|---|
Aspergillaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Myrothecium roridum | 62969 | Fungi | ||
Penicillium wortmannii | 5073 | Aspergillaceae | Fungi |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1418590 |
CHEMBL1741321
(1)
|
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL428496 |
CHEMBL872196
(1)
|
0 / 0 |
Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL428496 |
CHEMBL1062820
(1)
|
1 / 1 |
P42338 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Enzyme | CHEMBL428496 |
CHEMBL871586
(1)
CHEMBL1646726
(1)
CHEMBL2217264 (1) |
0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL1418590 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
|
7 / 44 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | CHEMBL428496 |
CHEMBL1061086
(1)
|
0 / 0 |
Q8TDX7 | Serine/threonine-protein kinase Nek7 | Nek | CHEMBL428496 |
CHEMBL1060151
(1)
|
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL295038 |
CHEMBL1613842
(1)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL295038 |
CHEMBL1794367
(1)
CHEMBL2114784
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL428496 CHEMBL295038 |
CHEMBL1794499
(3)
|
2 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | CHEMBL1418590 |
CHEMBL1614177
(1)
CHEMBL1614265
(1)
|
0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL295038 |
CHEMBL1794573
(1)
|
2 / 2 |
P78527 | DNA-dependent protein kinase catalytic subunit | Atypical serine/threonine protein kinase PIKK subfamily | CHEMBL428496 |
CHEMBL829682
(1)
CHEMBL2183424
(1)
|
0 / 0 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | CHEMBL428496 |
CHEMBL1052111
(1)
CHEMBL1249570
(1)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL428496 |
CHEMBL1063767
(1)
CHEMBL1249569
(1)
|
0 / 0 |
O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | CHEMBL428496 |
CHEMBL1063811
(1)
|
0 / 0 |
P41240 | Tyrosine-protein kinase CSK | Csk | CHEMBL428496 |
CHEMBL1061954
(1)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL295038 |
CHEMBL1614175
(1)
|
1 / 1 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | CHEMBL428496 |
CHEMBL829681
(1)
CHEMBL866276
(1)
CHEMBL871583 (1) CHEMBL979105 (1) CHEMBL979106 (1) CHEMBL1064071 (1) CHEMBL1633056 (1) CHEMBL1646725 (1) CHEMBL2161901 (1) CHEMBL2217265 (1) CHEMBL2327633 (1) |
9 / 1 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | CHEMBL428496 |
CHEMBL1060122
(1)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL428496 |
CHEMBL1062776
(1)
CHEMBL1249578
(1)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL428496 |
CHEMBL1061959
(1)
|
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL428496 |
CHEMBL1794585
(1)
|
0 / 0 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | CHEMBL428496 |
CHEMBL1051374
(1)
CHEMBL1249589
(1)
|
0 / 0 |
Q8IWQ3 | Serine/threonine-protein kinase BRSK2 | CAMK serine/threonine protein kinase BRSK subfamily | CHEMBL428496 |
CHEMBL1051367
(1)
|
0 / 0 |
P27448 | MAP/microtubule affinity-regulating kinase 3 | CAMK serine/threonine protein kinase MARK subfamily | CHEMBL428496 |
CHEMBL1063734
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL295038 |
CHEMBL1614310
(1)
CHEMBL1614544
(1)
|
11 / 10 |
P37840 | Alpha-synuclein | Unclassified protein | CHEMBL428496 CHEMBL295038 |
CHEMBL2354282
(3)
|
4 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL428496 CHEMBL295038 |
CHEMBL1614554
(4)
CHEMBL1613776
(4)
|
3 / 1 |
Q05513 | Protein kinase C zeta type | Iota | CHEMBL428496 |
CHEMBL1052114
(1)
|
0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL428496 |
CHEMBL1063736
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1418590 |
CHEMBL1741325
(1)
|
0 / 1 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | CHEMBL428496 |
CHEMBL1052119
(1)
CHEMBL1249582
(1)
|
0 / 0 |
Q9UQB9 | Aurora kinase C | Aur | CHEMBL428496 |
CHEMBL1062797
(1)
|
1 / 1 |
Q9HBH9 | MAP kinase-interacting serine/threonine-protein kinase 2 | CAMK serine/threonine protein kinase MNK subfamily | CHEMBL428496 |
CHEMBL1060126
(1)
|
0 / 0 |
Q9NQU5 | Serine/threonine-protein kinase PAK 6 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL428496 |
CHEMBL1063719
(1)
|
0 / 0 |
Q16644 | MAP kinase-activated protein kinase 3 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL428496 |
CHEMBL1061148
(1)
|
0 / 0 |
Q9H422 | Homeodomain-interacting protein kinase 3 | CMGC dual-specificity kinase HIPK | CHEMBL428496 |
CHEMBL1061964
(1)
|
0 / 0 |
Q14680 | Maternal embryonic leucine zipper kinase | Melk | CHEMBL428496 |
CHEMBL1052104
(1)
|
0 / 0 |
Q9NYY3 | Serine/threonine-protein kinase PLK2 | Plk2 | CHEMBL428496 |
CHEMBL995301
(1)
|
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL295038 |
CHEMBL1614166
(1)
|
1 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL428496 CHEMBL295038 CHEMBL1418590 |
CHEMBL1794311
(6)
|
2 / 3 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | CHEMBL428496 |
CHEMBL805570
(1)
CHEMBL1061945
(1)
CHEMBL1062028 (1) CHEMBL1646347 (1) |
1 / 1 |
Q13188 | Serine/threonine-protein kinase 3 | STE serine/threonine protein kinase MST subfamily | CHEMBL428496 |
CHEMBL1060209
(1)
|
0 / 0 |
P31751 | RAC-beta serine/threonine-protein kinase | Akt | CHEMBL428496 |
CHEMBL1061917
(1)
|
2 / 2 |
O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | CHEMBL428496 |
CHEMBL1062767
(1)
CHEMBL1249575
(1)
|
0 / 0 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | CHEMBL428496 |
CHEMBL1062809
(1)
|
0 / 0 |
Q16513 | Serine/threonine-protein kinase N2 | Pkn | CHEMBL428496 |
CHEMBL1060217
(1)
|
0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | CHEMBL428496 |
CHEMBL1062021
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL428496 CHEMBL295038 CHEMBL1418590 |
CHEMBL1614458
(4)
|
0 / 0 |
Q8N5S9 | Calcium/calmodulin-dependent protein kinase kinase 1 | META serine/threonine protein kinase subfamily | CHEMBL428496 |
CHEMBL1061198
(1)
|
0 / 0 |
Q9P286 | Serine/threonine-protein kinase PAK 7 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL428496 |
CHEMBL1061163
(1)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1474372 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
Q96SB4 | SRSF protein kinase 1 | Srpk | CHEMBL428496 |
CHEMBL1060225
(1)
|
0 / 0 |
Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | CHEMBL428496 |
CHEMBL1062802
(1)
|
0 / 0 |
O43781 | Dual specificity tyrosine-phosphorylation-regulated kinase 3 | CMGC dual-specificity kinase DYRK2 | CHEMBL428496 |
CHEMBL1061956
(1)
|
0 / 0 |
O96013 | Serine/threonine-protein kinase PAK 4 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL428496 |
CHEMBL1061162
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL295038 |
CHEMBL1794486
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL428496 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL428496 CHEMBL295038 |
CHEMBL1613941
(1)
CHEMBL2114843
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL428496 |
CHEMBL1060118
(1)
CHEMBL1249583
(1)
|
0 / 0 |
Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | CHEMBL428496 |
CHEMBL1052116
(1)
|
0 / 0 |
O15264 | Mitogen-activated protein kinase 13 | p38 | CHEMBL428496 |
CHEMBL1060132
(1)
CHEMBL1249572
(1)
|
0 / 0 |
P53779 | Mitogen-activated protein kinase 10 | Jnk | CHEMBL428496 |
CHEMBL1060123
(1)
|
0 / 1 |
Q9H1R3 | Myosin light chain kinase 2, skeletal/cardiac muscle | Mlck | CHEMBL428496 |
CHEMBL1249784
(1)
|
1 / 0 |
P51955 | Serine/threonine-protein kinase Nek2 | Nek | CHEMBL428496 |
CHEMBL1062822
(1)
|
0 / 0 |
Q96RR4 | Calcium/calmodulin-dependent protein kinase kinase 2 | META serine/threonine protein kinase subfamily | CHEMBL428496 |
CHEMBL1052080
(1)
|
0 / 0 |
Q9H4B4 | Serine/threonine-protein kinase PLK3 | PLK serine/threonine protein kinase subfamily | CHEMBL428496 |
CHEMBL995295
(1)
CHEMBL995297
(1)
CHEMBL995298 (1) CHEMBL995299 (1) CHEMBL995300 (1) |
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL428496 |
CHEMBL2114810
(1)
|
7 / 3 |
Q9BUB5 | MAP kinase-interacting serine/threonine-protein kinase 1 | CAMK serine/threonine protein kinase MNK subfamily | CHEMBL428496 |
CHEMBL1063759
(1)
|
0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | CHEMBL428496 |
CHEMBL2114924
(1)
|
1 / 2 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL295038 CHEMBL1418590 |
CHEMBL1614257
(3)
CHEMBL1614410
(1)
CHEMBL1614531 (3) |
1 / 3 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | CHEMBL428496 |
CHEMBL1963863
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL295038 |
CHEMBL1794467
(1)
|
0 / 0 |
P48730 | Casein kinase I isoform delta | Ck1 | CHEMBL428496 |
CHEMBL1062001
(1)
|
1 / 0 |
Q96GD4 | Aurora kinase B | Aur | CHEMBL428496 |
CHEMBL1051365
(1)
|
0 / 0 |
P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL428496 |
CHEMBL1051342
(1)
CHEMBL1249574
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL428496 CHEMBL1418590 |
CHEMBL1052091
(1)
CHEMBL1249567
(1)
CHEMBL1613808 (1) |
0 / 0 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | CHEMBL428496 |
CHEMBL1061969
(1)
CHEMBL1249568
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1418590 |
CHEMBL1741322
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1418590 CHEMBL1474372 |
CHEMBL1613910
(1)
CHEMBL1614227
(2)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL295038 CHEMBL1418590 |
CHEMBL1614038
(2)
|
2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | CHEMBL295038 |
CHEMBL1614171
(1)
|
5 / 2 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL428496 |
CHEMBL995296
(1)
CHEMBL1052115
(1)
CHEMBL1062888 (1) CHEMBL2217230 (1) |
0 / 0 |
Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL428496 |
CHEMBL1061101
(1)
CHEMBL1249576
(1)
|
0 / 0 |
O75116 | Rho-associated protein kinase 2 | Rock | CHEMBL428496 |
CHEMBL1063671
(1)
|
0 / 0 |
O00329 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Enzyme | CHEMBL428496 |
CHEMBL871588
(1)
CHEMBL1646729
(1)
CHEMBL2217262 (1) |
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL1418590 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1418590 |
CHEMBL1614240
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL428496 |
CHEMBL1061172
(1)
CHEMBL1249580
(1)
|
4 / 1 |
Q15118 | [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial | Pdhk | CHEMBL428496 |
CHEMBL1249579
(1)
|
0 / 0 |
O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | CHEMBL428496 |
CHEMBL1063673
(1)
CHEMBL1249581
(1)
|
0 / 0 |
P51812 | Ribosomal protein S6 kinase alpha-3 | Rskb | CHEMBL428496 |
CHEMBL1063683
(1)
|
2 / 2 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1418590 |
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1418590 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1741324 (1) |
0 / 1 |
Q9HC98 | Serine/threonine-protein kinase Nek6 | Nek | CHEMBL428496 |
CHEMBL1060128
(1)
|
0 / 0 |
Q9H2X6 | Homeodomain-interacting protein kinase 2 | CMGC dual-specificity kinase HIPK | CHEMBL428496 |
CHEMBL1062015
(1)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL428496 CHEMBL295038 |
CHEMBL1794483
(2)
|
0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | CHEMBL295038 |
CHEMBL1614052
(1)
|
1 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL295038 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL428496 CHEMBL295038 CHEMBL1418590 |
CHEMBL1614250
(4)
CHEMBL1614421
(4)
CHEMBL1614502 (3) |
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL295038 |
CHEMBL1738402
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL428496 |
CHEMBL1738184
(1)
CHEMBL2114908
(1)
|
0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL428496 |
CHEMBL1249588
(1)
|
0 / 1 |
O96017 | Serine/threonine-protein kinase Chk2 | Rad53 | CHEMBL428496 |
CHEMBL1062000
(1)
|
4 / 1 |
Q14012 | Calcium/calmodulin-dependent protein kinase type 1 | Camk1 | CHEMBL428496 |
CHEMBL1051272
(1)
|
0 / 0 |
P07900 | Heat shock protein HSP 90-alpha | Other cytosolic protein | CHEMBL428496 |
CHEMBL1794333
(1)
|
0 / 0 |
P48736 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Enzyme | CHEMBL428496 |
CHEMBL871582
(1)
CHEMBL902509
(1)
CHEMBL1633057 (1) CHEMBL1646727 (1) CHEMBL2217263 (1) |
0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL428496 |
CHEMBL1062854
(1)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL428496 |
CHEMBL1062005
(1)
|
1 / 0 |
P53778 | Mitogen-activated protein kinase 12 | p38 | CHEMBL428496 |
CHEMBL1062773
(1)
CHEMBL1249571
(1)
|
0 / 0 |
O00418 | Eukaryotic elongation factor 2 kinase | Atypical serine/threonine protein kinase alpha subfamily | CHEMBL428496 |
CHEMBL1060113
(1)
|
0 / 0 |
Q8TD08 | Mitogen-activated protein kinase 15 | Mapk | CHEMBL428496 |
CHEMBL1062012
(1)
|
0 / 0 |
Q86V86 | Serine/threonine-protein kinase pim-3 | Pim | CHEMBL428496 |
CHEMBL1061912
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL295038 |
CHEMBL1794536
(2)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1418590 |
CHEMBL1613914
(1)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL428496 CHEMBL295038 CHEMBL1418590 |
CHEMBL1613829
(5)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL1418590 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL428496 CHEMBL295038 |
CHEMBL1738442
(5)
|
0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL428496 CHEMBL295038 |
CHEMBL2354311
(2)
|
1 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL295038 CHEMBL1418590 |
CHEMBL1614257
(3)
CHEMBL1614531
(3)
|
2 / 5 |
P20248 | Cyclin-A2 | Other cytosolic protein | CHEMBL428496 |
CHEMBL1056886
(1)
|
0 / 0 |
P78396 | Cyclin-A1 | Other cytosolic protein | CHEMBL428496 |
CHEMBL1056886
(1)
|
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL428496 |
CHEMBL1056886
(1)
|
0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL428496 |
CHEMBL1061205
(1)
|
0 / 0 |
P19784 | Casein kinase II subunit alpha' | Ck2 | CHEMBL428496 |
CHEMBL1061205
(1)
|
0 / 0 |
P67870 | Casein kinase II subunit beta | REG serine/threonine protein kinase family | CHEMBL428496 |
CHEMBL1061205
(1)
|
0 / 0 |
P27986 | Phosphatidylinositol 3-kinase regulatory subunit alpha | Enzyme | CHEMBL428496 |
CHEMBL866276
(1)
CHEMBL2161901
(1)
CHEMBL2327633 (1) |
2 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL428496 |
CHEMBL2114738
(1)
|
0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | CHEMBL428496 |
CHEMBL2114796
(1)
|
2 / 1 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | CHEMBL428496 |
CHEMBL2354287
(1)
|
1 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C009687 | 8647 |
ABCB11
ABC16 BRIC2 BSEP PFIC-2 PFIC2 PGY4 SPGP |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 | wortmannin results in decreased activity of ABCB11 protein |
decreases activity
|
protein |
20829430
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [4-hydroxyestradiol results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15050414
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased activity of and results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
19801633
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
11788791
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [C5 protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16116186
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Caffeine results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
18201823
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Capsaicin results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19139269
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Copper results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
16973122
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Copper Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
16973122
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15608143
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Estrone results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
21767602
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Hexanones results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
14757120
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Humic Substances results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19686714
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Hydrocarbons, Chlorinated results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
14757120
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16499871
16682453 17520698 |
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [IL8 results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
21742513
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17550345
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16116186
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of AKT1 protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation / increases reaction |
protein |
20562903
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Simvastatin promotes the reaction [[Nifedipine co-treated with Hydrogen Peroxide] results in increased phosphorylation of AKT1 protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation / increases reaction |
protein |
20562903
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
12482858
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
12614848
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22556157
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15980035
17513037 |
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
16973122
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15355987
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
16973122
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin promotes the reaction [evodiamine results in decreased phosphorylation of AKT1 protein] |
decreases phosphorylation
/ increases reaction |
protein |
20005289
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin results in decreased activity of AKT1 protein |
decreases activity
|
protein |
12556562
|
C009687 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | wortmannin results in decreased phosphorylation of AKT1 protein |
decreases phosphorylation
|
protein |
12640124
16059913 23178381 |
C009687 | 248 |
ALPI
IAP |
alkaline phosphatase, intestinal (EC:3.1.3.1) | wortmannin promotes the reaction [Methotrexate results in increased activity of ALPI protein] |
increases activity
/ increases reaction |
protein |
16598758
|
C009687 | 248 |
ALPI
IAP |
alkaline phosphatase, intestinal (EC:3.1.3.1) | wortmannin results in increased activity of ALPI protein |
increases activity
|
protein |
16598758
|
C009687 | 472 |
ATM
AT1 ATA ATC ATD ATDC ATE TEL1 TELO1 |
ataxia telangiectasia mutated (EC:2.7.11.1) | wortmannin inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of TP53 protein]] |
decreases reaction
/ increases phosphorylation / increases reaction |
protein |
15489221
|
C009687 | 472 |
ATM
AT1 ATA ATC ATD ATDC ATE TEL1 TELO1 |
ataxia telangiectasia mutated (EC:2.7.11.1) | wortmannin inhibits the reaction [Mustard Gas results in increased phosphorylation of ATM protein] |
decreases reaction
/ increases phosphorylation |
protein |
22119920
|
C009687 | 572 |
BAD
BBC2 BCL2L8 |
BCL2-associated agonist of cell death | wortmannin inhibits the reaction [Acrolein results in increased phosphorylation of BAD protein] |
decreases reaction
/ increases phosphorylation |
protein |
19596284
|
C009687 | 572 |
BAD
BBC2 BCL2L8 |
BCL2-associated agonist of cell death | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of BAD protein] |
decreases reaction
/ increases phosphorylation |
protein |
15608143
|
C009687 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | wortmannin inhibits the reaction [Leukotriene B4 results in increased expression of BAX protein] |
decreases reaction
/ increases expression |
protein |
15970427
|
C009687 | 9564 |
BCAR1
CAS CAS1 CASS1 CRKAS P130Cas |
breast cancer anti-estrogen resistance 1 | Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of BCAR1 protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 9564 |
BCAR1
CAS CAS1 CASS1 CRKAS P130Cas |
breast cancer anti-estrogen resistance 1 | [oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of BCAR1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 9564 |
BCAR1
CAS CAS1 CASS1 CRKAS P130Cas |
breast cancer anti-estrogen resistance 1 | wortmannin inhibits the reaction [oxotremorine M results in increased phosphorylation of BCAR1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
10537051
|
C009687 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | wortmannin inhibits the reaction [Ethanol results in increased expression of BCL2 protein] |
decreases reaction
/ increases expression |
protein |
21410490
|
C009687 | 8678 |
BECN1
ATG6 VPS30 beclin1 |
beclin 1, autophagy related | wortmannin promotes the reaction [Ethanol results in increased degradation of BECN1 protein] |
increases degradation
/ increases reaction |
protein |
21410490
|
C009687 | 329 |
BIRC2
API1 HIAP2 Hiap-2 MIHB RNF48 c-IAP1 cIAP1 |
baculoviral IAP repeat containing 2 | wortmannin inhibits the reaction [Acrolein results in increased expression of BIRC2 protein] |
decreases reaction
/ increases expression |
protein |
19596284
|
C009687 | 329 |
BIRC2
API1 HIAP2 Hiap-2 MIHB RNF48 c-IAP1 cIAP1 |
baculoviral IAP repeat containing 2 | wortmannin results in decreased expression of BIRC2 mRNA |
decreases expression
|
mRNA |
15065019
|
C009687 | 329 |
BIRC2
API1 HIAP2 Hiap-2 MIHB RNF48 c-IAP1 cIAP1 |
baculoviral IAP repeat containing 2 | wortmannin results in decreased expression of BIRC2 protein |
decreases expression
|
protein |
15065019
|
C009687 | 330 |
BIRC3
AIP1 API2 CIAP2 HAIP1 HIAP1 MALT2 MIHC RNF49 c-IAP2 |
baculoviral IAP repeat containing 3 | wortmannin inhibits the reaction [Acrolein results in increased expression of BIRC3 protein] |
decreases reaction
/ increases expression |
protein |
19596284
|
C009687 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | wortmannin results in decreased expression of BIRC5 mRNA |
decreases expression
|
mRNA |
15065019
|
C009687 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | wortmannin results in decreased expression of BIRC5 protein |
decreases expression
|
protein |
15065019
|
C009687 | 727 |
C5
C5a C5b CPAMD4 |
complement component 5 | wortmannin inhibits the reaction [C5 protein results in decreased expression of IL12A mRNA] |
decreases expression
/ decreases reaction |
protein |
16116186
|
C009687 | 727 |
C5
C5a C5b CPAMD4 |
complement component 5 | wortmannin inhibits the reaction [C5 protein results in decreased expression of [IL12A protein binds to IL12B protein]] |
affects binding
/ decreases expression / decreases reaction |
protein |
16116186
|
C009687 | 727 |
C5
C5a C5b CPAMD4 |
complement component 5 | wortmannin inhibits the reaction [C5 protein results in decreased expression of IL12B mRNA] |
decreases expression
/ decreases reaction |
protein |
16116186
|
C009687 | 727 |
C5
C5a C5b CPAMD4 |
complement component 5 | wortmannin inhibits the reaction [C5 protein results in decreased expression of IL23A mRNA] |
decreases expression
/ decreases reaction |
protein |
16116186
|
C009687 | 727 |
C5
C5a C5b CPAMD4 |
complement component 5 | wortmannin inhibits the reaction [C5 protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16116186
|
C009687 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | ABT-737 promotes the reaction [wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP3 protein]] |
increases cleavage
/ increases reaction |
protein |
20104024
|
C009687 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP3 protein] |
increases cleavage
/ increases reaction |
protein |
20104024
|
C009687 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of CASP3 protein] |
increases activity
/ increases cleavage / increases reaction |
protein |
17935137
|
C009687 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | wortmannin promotes the reaction [Etoposide results in increased cleavage of and results in increased activity of CASP3 protein] |
increases activity
/ increases cleavage / increases reaction |
protein |
17935137
|
C009687 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | ABT-737 promotes the reaction [wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP8 protein]] |
increases cleavage
/ increases reaction |
protein |
20104024
|
C009687 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP8 protein] |
increases cleavage
/ increases reaction |
protein |
20104024
|
C009687 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | ABT-737 promotes the reaction [wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP9 protein]] |
increases cleavage
/ increases reaction |
protein |
20104024
|
C009687 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | wortmannin promotes the reaction [celecoxib results in increased cleavage of CASP9 protein] |
increases cleavage
/ increases reaction |
protein |
20104024
|
C009687 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein] |
increases cleavage
/ increases reaction |
protein |
17935137
|
C009687 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | wortmannin promotes the reaction [Etoposide results in increased cleavage of CASP9 protein] |
increases cleavage
/ increases reaction |
protein |
17935137
|
C009687 | 857 |
CAV1
BSCL3 CGL3 MSTP085 PPH3 VIP21 CAV |
caveolin 1, caveolae protein, 22kDa | wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to Hydrogen Peroxide] |
decreases reaction
/ increases response to substance |
protein |
12640124
|
C009687 | 857 |
CAV1
BSCL3 CGL3 MSTP085 PPH3 VIP21 CAV |
caveolin 1, caveolae protein, 22kDa | wortmannin inhibits the reaction [CAV1 protein results in increased susceptibility to sodium arsenite] |
decreases reaction
/ increases response to substance |
protein |
12640124
|
C009687 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | wortmannin inhibits the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CCND1 protein] |
decreases reaction
/ increases expression |
protein |
19801633
|
C009687 | 894 |
CCND2
KIAK0002 |
cyclin D2 | wortmannin results in decreased methylation of CCND2 promoter |
decreases methylation
|
promoter |
14745455
|
C009687 | 894 |
CCND2
KIAK0002 |
cyclin D2 | wortmannin results in increased expression of CCND2 mRNA |
increases expression
|
mRNA |
14745455
|
C009687 | 1232 |
CCR3
CC-CKR-3 CD193 CKR3 CMKBR3 |
chemokine (C-C motif) receptor 3 | wortmannin inhibits the reaction [IL3 protein results in decreased expression of CCR3 protein] |
decreases expression
/ decreases reaction |
protein |
11544337
|
C009687 | 948 |
CD36
BDPLT10 CHDS7 FAT GP3B GP4 GPIV PASIV SCARB3 |
CD36 molecule (thrombospondin receptor) | wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of CD36 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19640849
|
C009687 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | wortmannin inhibits the reaction [Aspirin results in increased expression of CDKN1A protein] |
decreases reaction
/ increases expression |
protein |
21617849
|
C009687 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | wortmannin inhibits the reaction [docetaxel results in increased expression of CDKN1A protein] |
decreases reaction
/ increases expression |
protein |
20878124
|
C009687 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | wortmannin results in decreased expression of CDKN1A protein |
decreases expression
|
protein |
22290291
|
C009687 | 1027 |
CDKN1B
CDKN4 KIP1 MEN1B MEN4 P27KIP1 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) | wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] |
increases expression
/ increases reaction |
protein |
17935137
|
C009687 | 1027 |
CDKN1B
CDKN4 KIP1 MEN1B MEN4 P27KIP1 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) | wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] |
increases expression
/ increases reaction |
protein |
17935137
|
C009687 | 1080 |
CFTR
ABC35 ABCC7 CF CFTR/MRP MRP7 TNR-CFTR dJ760C5.1 |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) | wortmannin inhibits the reaction [CGP 12177 results in increased activity of CFTR protein] |
decreases reaction
/ increases activity |
protein |
15563584
|
C009687 | 1111 |
CHEK1
CHK1 |
checkpoint kinase 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
19261750
|
C009687 | 1111 |
CHEK1
CHK1 |
checkpoint kinase 1 (EC:2.7.11.1) | wortmannin inhibits the reaction [Mustard Gas results in increased phosphorylation of CHEK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22119920
|
C009687 | 1111 |
CHEK1
CHK1 |
checkpoint kinase 1 (EC:2.7.11.1) | wortmannin results in decreased expression of CHEK1 protein |
decreases expression
|
protein |
22409540
|
C009687 | 11200 |
CHEK2
CDS1 CHK2 HuCds1 LFS2 PP1425 RAD53 hCds1 |
checkpoint kinase 2 (EC:2.7.11.1) | wortmannin inhibits the reaction [2-chloroethyl ethyl sulfide results in increased phosphorylation of CHEK2 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19111594
|
C009687 | 11200 |
CHEK2
CDS1 CHK2 HuCds1 LFS2 PP1425 RAD53 hCds1 |
checkpoint kinase 2 (EC:2.7.11.1) | wortmannin inhibits the reaction [Mustard Gas results in increased phosphorylation of CHEK2 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22119920
|
C009687 | 11200 |
CHEK2
CDS1 CHK2 HuCds1 LFS2 PP1425 RAD53 hCds1 |
checkpoint kinase 2 (EC:2.7.11.1) | wortmannin results in decreased phosphorylation of CHEK2 protein |
decreases phosphorylation
|
protein |
22119920
|
C009687 | 80781 |
COL18A1
KNO KNO1 KS |
collagen, type XVIII, alpha 1 | wortmannin inhibits the reaction [cobaltous chloride results in decreased expression of COL18A1 mRNA] |
decreases expression
/ decreases reaction |
mRNA |
13679210
|
C009687 | 80781 |
COL18A1
KNO KNO1 KS |
collagen, type XVIII, alpha 1 | wortmannin inhibits the reaction [cobaltous chloride results in decreased expression of COL18A1 protein] |
decreases expression
/ decreases reaction |
protein |
13679210
|
C009687 | 1278 |
COL1A2
OI4 |
collagen, type I, alpha 2 | wortmannin inhibits the reaction [Acetaldehyde results in increased expression of COL1A2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
11343241
|
C009687 | 1385 |
CREB1
CREB |
cAMP responsive element binding protein 1 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of CREB1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15608143
|
C009687 | 1499 |
CTNNB1
CTNNB MRD19 armadillo |
catenin (cadherin-associated protein), beta 1, 88kDa | wortmannin results in decreased expression of CTNNB1 protein |
decreases expression
|
protein |
11739494
|
C009687 | 2920 |
CXCL2
CINC-2a GRO2 GROb MGSA-b MIP-2a MIP2 MIP2A SCYB2 |
chemokine (C-X-C motif) ligand 2 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15608143
|
C009687 | 2920 |
CXCL2
CINC-2a GRO2 GROb MGSA-b MIP-2a MIP2 MIP2A SCYB2 |
chemokine (C-X-C motif) ligand 2 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15608143
|
C009687 | 2920 |
CXCL2
CINC-2a GRO2 GROb MGSA-b MIP-2a MIP2 MIP2A SCYB2 |
chemokine (C-X-C motif) ligand 2 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15608143
|
C009687 | 2920 |
CXCL2
CINC-2a GRO2 GROb MGSA-b MIP-2a MIP2 MIP2A SCYB2 |
chemokine (C-X-C motif) ligand 2 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of BAD protein] |
decreases reaction
/ increases phosphorylation |
protein |
15608143
|
C009687 | 2920 |
CXCL2
CINC-2a GRO2 GROb MGSA-b MIP-2a MIP2 MIP2A SCYB2 |
chemokine (C-X-C motif) ligand 2 | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of CREB1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15608143
|
C009687 | 3579 |
CXCR2
CD182 CDw128b CMKAR2 IL8R2 IL8RA IL8RB |
chemokine (C-X-C motif) receptor 2 | wortmannin inhibits the reaction [IL8 protein results in increased activity of CXCR2 protein] |
decreases reaction
/ increases activity |
protein |
12975484
|
C009687 | 199974 |
CYP4Z1
CYP4A20 |
cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) | wortmannin inhibits the reaction [CYP4Z1 protein results in increased expression of TIMP2 mRNA] |
decreases reaction
/ increases expression |
protein |
22841774
|
C009687 | 199974 |
CYP4Z1
CYP4A20 |
cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) | wortmannin inhibits the reaction [CYP4Z1 protein results in increased expression of VEGFA mRNA] |
decreases reaction
/ increases expression |
protein |
22841774
|
C009687 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | wortmannin inhibits the reaction [Curcumin results in increased expression of DDIT3 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17171638
|
C009687 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | wortmannin inhibits the reaction [Curcumin results in increased expression of DDIT3 protein] |
decreases reaction
/ increases expression |
protein |
17171638
|
C009687 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 1978 |
EIF4EBP1
4E-BP1 4EBP1 BP-1 PHAS-I |
eukaryotic translation initiation factor 4E binding protein 1 | wortmannin inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4EBP1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
12569580
|
C009687 | 2057 |
EPOR
EPO-R |
erythropoietin receptor | wortmannin inhibits the reaction [testosterone-3-carboxymethyloxime-bovine serum albumin conjugate results in increased expression of EPOR mRNA] |
decreases reaction
/ increases expression |
mRNA |
20189893
|
C009687 | 2152 |
F3
CD142 TF TFA |
coagulation factor III (thromboplastin, tissue factor) | wortmannin promotes the reaction [Histamine results in increased expression of F3] |
increases expression
/ increases reaction |
16009787
|
|
C009687 | 356 |
FASLG
ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 |
Fas ligand (TNF superfamily, member 6) | wortmannin inhibits the reaction [evodiamine results in increased expression of FASLG protein] |
decreases reaction
/ increases expression |
protein |
20005289
|
C009687 | 2252 |
FGF7
HBGF-7 KGF |
fibroblast growth factor 7 | wortmannin inhibits the reaction [FGF7 protein results in increased expression of PLAC1 mRNA] |
decreases reaction
/ increases expression |
protein |
15803460
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Copper affects the localization of FOXO1 protein] |
affects localization
/ decreases reaction |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Copper results in increased phosphorylation of FOXO1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Copper Sulfate affects the localization of FOXO1 protein] |
affects localization
/ decreases reaction |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Copper Sulfate results in increased phosphorylation of FOXO1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Doxorubicin results in increased phosphorylation of FOXO1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17935137
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Etoposide results in increased phosphorylation of FOXO1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17935137
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Zinc affects the localization of FOXO1 protein] |
affects localization
/ decreases reaction |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of FOXO1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Zinc Sulfate affects the localization of FOXO1 protein] |
affects localization
/ decreases reaction |
protein |
16973122
|
C009687 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of FOXO1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 2309 |
FOXO3
AF6q21 FKHRL1 FKHRL1P2 FOXO2 FOXO3A |
forkhead box O3 | wortmannin inhibits the reaction [Doxorubicin results in increased phosphorylation of FOXO3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17935137
|
C009687 | 2309 |
FOXO3
AF6q21 FKHRL1 FKHRL1P2 FOXO2 FOXO3A |
forkhead box O3 | wortmannin inhibits the reaction [Etoposide results in increased phosphorylation of FOXO3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17935137
|
C009687 | 4303 |
FOXO4
AFX AFX1 MLLT7 |
forkhead box O4 | wortmannin inhibits the reaction [Copper results in increased phosphorylation of FOXO4 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 4303 |
FOXO4
AFX AFX1 MLLT7 |
forkhead box O4 | wortmannin inhibits the reaction [Copper Sulfate results in increased phosphorylation of FOXO4 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 4303 |
FOXO4
AFX AFX1 MLLT7 |
forkhead box O4 | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of FOXO4 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 4303 |
FOXO4
AFX AFX1 MLLT7 |
forkhead box O4 | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of FOXO4 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16973122
|
C009687 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | wortmannin results in increased expression of GDF15 protein |
increases expression
|
protein |
23178381
|
C009687 | 2932 |
GSK3B
|
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | wortmannin inhibits the reaction [Estradiol results in increased phosphorylation of GSK3B protein] |
decreases reaction
/ increases phosphorylation |
protein |
16076840
|
C009687 | 2932 |
GSK3B
|
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | wortmannin inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of GSK3B protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
12614848
|
C009687 | 2932 |
GSK3B
|
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of GSK3B protein] |
decreases reaction
/ increases phosphorylation |
protein |
17513037
|
C009687 | 2932 |
GSK3B
|
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | wortmannin results in decreased phosphorylation of GSK3B protein |
decreases phosphorylation
|
protein |
20090934
23178381 |
C009687 | 3014 |
H2AFX
H2A.X H2A/X H2AX |
H2A histone family, member X | wortmannin inhibits the reaction [decitabine results in increased expression of H2AFX protein] |
decreases reaction
/ increases expression |
protein |
17991895
|
C009687 | 3014 |
H2AFX
H2A.X H2A/X H2AX |
H2A histone family, member X | wortmannin promotes the reaction [docetaxel results in increased expression of H2AFX protein] |
increases expression
/ increases reaction |
protein |
20878124
|
C009687 | 3014 |
H2AFX
H2A.X H2A/X H2AX |
H2A histone family, member X | wortmannin promotes the reaction [Soil Pollutants results in increased phosphorylation of H2AFX protein] |
increases phosphorylation
/ increases reaction |
protein |
22409540
|
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | [wortmannin co-treated with U 0126] inhibits the reaction [IGF1 protein promotes the reaction [cobaltous chloride results in increased expression of HIF1A protein]] |
affects cotreatment
/ decreases reaction / increases expression / increases reaction |
protein |
16499871
|
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | wortmannin inhibits the reaction [4-hydroxyestradiol results in increased expression of HIF1A protein] |
decreases reaction
/ increases expression |
protein |
15050414
|
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | wortmannin inhibits the reaction [cobaltous chloride results in increased expression of HIF1A protein] |
decreases reaction
/ increases expression |
protein |
13679210
|
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | wortmannin inhibits the reaction [CR 3294 results in decreased expression of HIF1A protein] |
decreases expression
/ decreases reaction |
protein |
18927491
|
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | wortmannin inhibits the reaction [[Dinoprostone binds to and results in increased activity of PTGER1 protein] which results in increased expression of HIF1A protein] |
affects binding
/ decreases reaction / increases activity / increases expression |
protein |
20335389
|
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA] |
decreases reaction
/ increases expression |
mRNA |
11424089
19640849 |
C009687 | 3091 |
HIF1A
HIF-1A HIF-1alpha HIF1 HIF1-ALPHA MOP1 PASD8 bHLHe78 |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | wortmannin results in decreased expression of HIF1A protein |
decreases expression
|
protein |
14726529
|
C009687 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | wortmannin inhibits the reaction [Acrolein results in increased expression of HMOX1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
18048804
|
C009687 | 3162 |
HMOX1
HMOX1D HO-1 HSP32 bK286B10 |
heme oxygenase (decycling) 1 (EC:1.14.99.3) | wortmannin inhibits the reaction [plumbagin results in increased expression of HMOX1 protein] |
decreases reaction
/ increases expression |
protein |
20028456
|
C009687 | 3297 |
HSF1
HSTF1 |
heat shock transcription factor 1 | wortmannin affects the localization of HSF1 protein |
affects localization
|
protein |
20090934
|
C009687 | 3297 |
HSF1
HSTF1 |
heat shock transcription factor 1 | wortmannin inhibits the reaction [Oxygen deficiency results in increased expression of HSF1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
11424089
|
C009687 | 692420 | wortmannin results in decreased expression of HSP90 protein |
decreases expression
|
protein |
14726529
|
||
C009687 | 3303 |
HSPA1A
HSP70-1 HSP70-1A HSP70I HSP72 HSPA1 |
heat shock 70kDa protein 1A | wortmannin results in decreased expression of HSPA1A protein |
decreases expression
|
protein |
20090934
|
C009687 | 3303 |
HSPA1A
HSP70-1 HSP70-1A HSP70I HSP72 HSPA1 |
heat shock 70kDa protein 1A | wortmannin results in decreased expression of HSPA1A protein alternative form |
decreases expression
|
protein |
20090934
|
C009687 | 3309 |
HSPA5
BIP GRP78 MIF2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | wortmannin inhibits the reaction [Thapsigargin results in increased expression of HSPA5 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19428936
|
C009687 | 3458 |
IFNG
IFG IFI |
interferon, gamma | wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
16968468
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | [wortmannin co-treated with U 0126] inhibits the reaction [IGF1 protein promotes the reaction [cobaltous chloride results in increased expression of HIF1A protein]] |
affects cotreatment
/ decreases reaction / increases expression / increases reaction |
protein |
16499871
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of KCNH1 protein] |
decreases reaction
/ increases activity |
protein |
17520698
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
16499871
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity |
protein |
16499871
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of MTR protein] |
decreases reaction
/ increases activity |
protein |
14745455
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased expression of MYCN protein] |
decreases reaction
/ increases expression |
protein |
12569580
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein] |
decreases reaction
/ increases expression |
protein |
20733350
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16499871
16682453 17520698 |
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased phosphorylation of EIF4EBP1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
12569580
|
C009687 | 3479 |
IGF1
IGF-I IGF1A IGFI |
insulin-like growth factor 1 (somatomedin C) | wortmannin inhibits the reaction [IGF1 protein results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
16499871
|
C009687 | 3592 |
IL12A
CLMF IL-12A NFSK NKSF1 P35 |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | wortmannin inhibits the reaction [C5 protein results in decreased expression of IL12A mRNA] |
decreases expression
/ decreases reaction |
mRNA |
16116186
|
C009687 | 3592 |
IL12A
CLMF IL-12A NFSK NKSF1 P35 |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | wortmannin inhibits the reaction [C5 protein results in decreased expression of [IL12A protein binds to IL12B protein]] |
affects binding
/ decreases expression / decreases reaction |
protein |
16116186
|
C009687 | 3592 |
IL12A
CLMF IL-12A NFSK NKSF1 P35 |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]] |
affects binding
/ decreases expression / decreases reaction |
protein |
16116186
|
C009687 | 3593 |
IL12B
CLMF CLMF2 IL-12B NKSF NKSF2 |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | wortmannin inhibits the reaction [C5 protein results in decreased expression of [IL12A protein binds to IL12B protein]] |
affects binding
/ decreases expression / decreases reaction |
protein |
16116186
|
C009687 | 3593 |
IL12B
CLMF CLMF2 IL-12B NKSF NKSF2 |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | wortmannin inhibits the reaction [C5 protein results in decreased expression of IL12B mRNA] |
decreases expression
/ decreases reaction |
mRNA |
16116186
|
C009687 | 3593 |
IL12B
CLMF CLMF2 IL-12B NKSF NKSF2 |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | wortmannin inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of [IL12A protein binds to IL12B protein]] |
affects binding
/ decreases expression / decreases reaction |
protein |
16116186
|
C009687 | 3552 |
IL1A
IL-1A IL1 IL1-ALPHA IL1F1 |
interleukin 1, alpha | wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
16968468
|
C009687 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | wortmannin inhibits the reaction [IL1B protein results in increased activity of MMP12 protein] |
decreases reaction
/ increases activity |
protein |
16359550
|
C009687 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | wortmannin inhibits the reaction [IL1B protein results in increased expression of MMP12 mRNA] |
decreases reaction
/ increases expression |
protein |
16359550
|
C009687 | 51561 |
IL23A
IL-23 IL-23A IL23P19 P19 SGRF |
interleukin 23, alpha subunit p19 | wortmannin inhibits the reaction [C5 protein results in decreased expression of IL23A mRNA] |
decreases expression
/ decreases reaction |
mRNA |
16116186
|
C009687 | 3562 |
IL3
IL-3 MCGF MULTI-CSF |
interleukin 3 (colony-stimulating factor, multiple) | wortmannin inhibits the reaction [IL3 protein results in decreased expression of CCR3 protein] |
decreases expression
/ decreases reaction |
protein |
11544337
|
C009687 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | wortmannin inhibits the reaction [IL8 protein results in increased activity of CXCR2 protein] |
decreases reaction
/ increases activity |
protein |
12975484
|
C009687 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | wortmannin inhibits the reaction [IL8 results in decreased susceptibility to Cisplatin] |
decreases reaction
/ decreases response to substance |
21742513
|
|
C009687 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | wortmannin inhibits the reaction [IL8 results in decreased susceptibility to Paclitaxel] |
decreases reaction
/ decreases response to substance |
21742513
|
|
C009687 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | wortmannin inhibits the reaction [IL8 results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
21742513
|
|
C009687 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | wortmannin inhibits the reaction [nickel subsulfide results in increased expression of IL8 mRNA] |
decreases reaction
/ increases expression |
mRNA |
11978798
|
C009687 | 3630 |
INS
IDDM2 ILPR IRDN MODY10 |
insulin | [wortmannin co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein] |
affects cotreatment
/ affects localization / decreases reaction |
protein |
11574405
|
C009687 | 3630 |
INS
IDDM2 ILPR IRDN MODY10 |
insulin | wortmannin inhibits the reaction [INS protein results in decreased susceptibility to Coumaric Acids] |
decreases reaction
/ decreases response to substance |
protein |
20015842
|
C009687 | 3630 |
INS
IDDM2 ILPR IRDN MODY10 |
insulin | wortmannin inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17550345
|
C009687 | 3685 |
ITGAV
CD51 MSK8 VNRA VTNR |
integrin, alpha V | wortmannin inhibits the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]] |
affects activity
/ affects binding / affects localization / decreases reaction |
protein |
15213856
|
C009687 | 3689 |
ITGB2
CD18 LAD LCAMB LFA-1 MAC-1 MF17 MFI7 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | wortmannin inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein] |
decreases reaction
/ increases activity |
protein |
16963453
|
C009687 | 3690 |
ITGB3
BDPLT16 BDPLT2 CD61 GP3A GPIIIa GT |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | wortmannin inhibits the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]] |
affects activity
/ affects binding / affects localization / decreases reaction |
protein |
15213856
|
C009687 | 3756 |
KCNH1
EAG EAG1 Kv10.1 h-eag |
potassium voltage-gated channel, subfamily H (eag-related), member 1 | wortmannin inhibits the reaction [IGF1 protein results in increased activity of KCNH1 protein] |
decreases reaction
/ increases activity |
protein |
17520698
|
C009687 | 3978 |
LIG1
|
ligase I, DNA, ATP-dependent (EC:6.5.1.1) | wortmannin inhibits the reaction [2-chloroethyl ethyl sulfide results in increased phosphorylation of LIG1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16700562
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | [bisindolylmaleimide I co-treated with wortmannin] inhibits the reaction [Zinc results in increased phosphorylation of MAPK1 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
20522546
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | KN 93 promotes the reaction [wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK1 protein]] |
decreases reaction
/ increases phosphorylation / increases reaction |
protein |
15355987
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
19477951
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15608143
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
16499871
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
20522546
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15355987
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin promotes the reaction [KN 93 inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK1 protein]] |
decreases reaction
/ increases phosphorylation / increases reaction |
protein |
15355987
|
C009687 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | wortmannin results in increased phosphorylation of MAPK1 protein |
increases phosphorylation
|
protein |
19139269
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | [bisindolylmaleimide I co-treated with wortmannin] inhibits the reaction [Zinc results in increased phosphorylation of MAPK3 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
20522546
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | KN 93 promotes the reaction [wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK3 protein]] |
decreases reaction
/ increases phosphorylation / increases reaction |
protein |
15355987
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
19477951
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin inhibits the reaction [CXCL2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15608143
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity |
protein |
16499871
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin inhibits the reaction [Zinc results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
20522546
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15355987
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin promotes the reaction [KN 93 inhibits the reaction [Zinc Sulfate results in increased phosphorylation of MAPK3 protein]] |
decreases reaction
/ increases phosphorylation / increases reaction |
protein |
15355987
|
C009687 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | wortmannin results in increased phosphorylation of MAPK3 protein |
increases phosphorylation
|
protein |
19139269
|
C009687 | 4170 |
MCL1
BCL2L3 EAT MCL1-ES MCL1L MCL1S Mcl-1 TM bcl2-L-3 mcl1/EAT |
myeloid cell leukemia sequence 1 (BCL2-related) | wortmannin inhibits the reaction [Leukotriene B4 results in increased expression of MCL1 protein] |
decreases reaction
/ increases expression |
protein |
15970427
|
C009687 | 4170 |
MCL1
BCL2L3 EAT MCL1-ES MCL1L MCL1S Mcl-1 TM bcl2-L-3 mcl1/EAT |
myeloid cell leukemia sequence 1 (BCL2-related) | wortmannin promotes the reaction [Doxorubicin results in decreased expression of MCL1 protein] |
decreases expression
/ increases reaction |
protein |
17935137
|
C009687 | 4170 |
MCL1
BCL2L3 EAT MCL1-ES MCL1L MCL1S Mcl-1 TM bcl2-L-3 mcl1/EAT |
myeloid cell leukemia sequence 1 (BCL2-related) | wortmannin promotes the reaction [Etoposide results in decreased expression of MCL1 protein] |
decreases expression
/ increases reaction |
protein |
17935137
|
C009687 | 4193 |
MDM2
ACTFS HDMX hdm2 |
MDM2 oncogene, E3 ubiquitin protein ligase | wortmannin promotes the reaction [Doxorubicin results in increased phosphorylation of MDM2 protein] |
increases phosphorylation
/ increases reaction |
protein |
17935137
|
C009687 | 4193 |
MDM2
ACTFS HDMX hdm2 |
MDM2 oncogene, E3 ubiquitin protein ligase | wortmannin promotes the reaction [Etoposide results in increased phosphorylation of MDM2 protein] |
increases phosphorylation
/ increases reaction |
protein |
17935137
|
C009687 | 406991 |
MIR21
MIRN21 hsa-mir-21 miR-21 miRNA21 |
microRNA 21 | wortmannin inhibits the reaction [fludioxonil results in increased expression of MIR21 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23052036
|
C009687 | 406991 |
MIR21
MIRN21 hsa-mir-21 miR-21 miRNA21 |
microRNA 21 | wortmannin inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of MIR21 mRNA] |
decreases reaction
/ increases expression |
mRNA |
23052036
|
C009687 | 4321 |
MMP12
HME ME MME MMP-12 |
matrix metallopeptidase 12 (macrophage elastase) (EC:3.4.24.65) | wortmannin inhibits the reaction [IL1B protein results in increased activity of MMP12 protein] |
decreases reaction
/ increases activity |
protein |
16359550
|
C009687 | 4321 |
MMP12
HME ME MME MMP-12 |
matrix metallopeptidase 12 (macrophage elastase) (EC:3.4.24.65) | wortmannin inhibits the reaction [IL1B protein results in increased expression of MMP12 mRNA] |
decreases reaction
/ increases expression |
mRNA |
16359550
|
C009687 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | wortmannin promotes the reaction [ovatodiolide results in decreased activity of MMP9 protein] |
decreases activity
/ increases reaction |
protein |
22033475
|
C009687 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | wortmannin results in decreased activity of MMP9 protein |
decreases activity
|
protein |
22033475
|
C009687 | 4353 |
MPO
|
myeloperoxidase (EC:1.11.2.2) | wortmannin inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of MPO protein] |
decreases reaction
/ increases secretion |
protein |
18987595
|
C009687 | 4504 |
MT3
GIF GIFB GRIF ZnMT3 |
metallothionein 3 | wortmannin results in decreased susceptibility to MT3 protein |
decreases response to substance
|
protein |
19767621
|
C009687 | 2475 |
MTOR
FRAP FRAP1 FRAP2 RAFT1 RAPT1 |
mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) | wortmannin inhibits the reaction [Capsaicin results in increased phosphorylation of MTOR protein] |
decreases reaction
/ increases phosphorylation |
protein |
19139269
|
C009687 | 4548 |
MTR
HMAG MS cblG |
5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) | wortmannin inhibits the reaction [Dopamine results in increased activity of MTR protein] |
decreases reaction
/ increases activity |
protein |
14745455
|
C009687 | 4548 |
MTR
HMAG MS cblG |
5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) | wortmannin inhibits the reaction [IGF1 protein results in increased activity of MTR protein] |
decreases reaction
/ increases activity |
protein |
14745455
|
C009687 | 4613 |
MYCN
MODED MYCNOT N-myc NMYC ODED bHLHe37 |
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog | wortmannin inhibits the reaction [IGF1 protein results in increased expression of MYCN protein] |
decreases reaction
/ increases expression |
protein |
12569580
|
C009687 | 58498 |
MYL7
MYL2A MYLC2A |
myosin, light chain 7, regulatory | wortmannin inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15621049
|
C009687 | 58498 |
MYL7
MYL2A MYLC2A |
myosin, light chain 7, regulatory | wortmannin results in decreased phosphorylation of MYL7 protein |
decreases phosphorylation
|
protein |
15621049
|
C009687 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | wortmannin inhibits the reaction [Doxorubicin results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation |
protein |
17935137
|
C009687 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | wortmannin inhibits the reaction [Etoposide results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation |
protein |
17935137
|
C009687 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | wortmannin inhibits the reaction [evodiamine results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation / increases phosphorylation |
protein |
20005289
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | Fenofibrate inhibits the reaction [wortmannin results in decreased phosphorylation of NOS3 protein] |
decreases phosphorylation
/ decreases reaction |
protein |
16442496
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of NOS3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
11788791
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [diallyl disulfide results in increased phosphorylation of NOS3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
20229525
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [diallyl trisulfide results in increased phosphorylation of NOS3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
20229525
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]] |
affects cotreatment
/ decreases reaction / increases expression / increases phosphorylation / increases reaction |
protein |
20562903
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]] |
decreases reaction
/ increases activity / increases reaction |
protein |
15358673
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [Progesterone results in increased activity of NOS3 protein] |
decreases reaction
/ increases activity |
protein |
15358673
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [Progesterone results in increased phosphorylation of NOS3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
18710710
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
18296501
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]] |
decreases phosphorylation
/ decreases reaction |
protein |
19767878
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]] |
decreases phosphorylation
/ decreases reaction / increases abundance |
protein |
19767878
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin inhibits the reaction [Simvastatin promotes the reaction [[Hydrogen Peroxide co-treated with Nifedipine] results in increased phosphorylation of and results in increased expression of NOS3 protein]] |
affects cotreatment
/ decreases reaction / increases expression / increases phosphorylation / increases reaction |
protein |
20562903
|
C009687 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | wortmannin results in decreased phosphorylation of NOS3 protein |
decreases phosphorylation
|
protein |
16442496
|
C009687 | 1728 |
NQO1
DHQU DIA4 DTD NMOR1 NMORI QR1 |
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) | wortmannin inhibits the reaction [plumbagin results in increased expression of NQO1 protein] |
decreases reaction
/ increases expression |
protein |
20028456
|
C009687 | 2516 |
NR5A1
AD4BP ELP FTZ1 FTZF1 POF7 SF-1 SF1 SPGF8 SRXY3 |
nuclear receptor subfamily 5, group A, member 1 | wortmannin inhibits the reaction [Estradiol results in increased activity of NR5A1 protein] |
decreases reaction
/ increases activity |
protein |
19549922
|
C009687 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 4922 |
NTS
NMN-125 NN NT NT/N NTS1 |
neurotensin | wortmannin inhibits the reaction [NTS protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15177934
|
C009687 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | wortmannin promotes the reaction [Doxorubicin results in increased cleavage of PARP1 protein] |
increases cleavage
/ increases reaction |
protein |
17935137
|
C009687 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | wortmannin promotes the reaction [Etoposide results in increased cleavage of PARP1 protein] |
increases cleavage
/ increases reaction |
protein |
17935137
|
C009687 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | wortmannin promotes the reaction [sodium arsenite results in increased degradation of PARP1 protein] |
increases degradation
/ increases reaction |
protein |
12614848
|
C009687 | 27250 |
PDCD4
H731 |
programmed cell death 4 (neoplastic transformation inhibitor) | wortmannin results in increased expression of PDCD4 mRNA |
increases expression
|
mRNA |
17259349
|
C009687 | 27250 |
PDCD4
H731 |
programmed cell death 4 (neoplastic transformation inhibitor) | wortmannin results in increased expression of PDCD4 protein |
increases expression
|
protein |
17259349
|
C009687 | 3651 |
PDX1
GSF IDX-1 IPF1 IUF1 MODY4 PDX-1 STF-1 |
pancreatic and duodenal homeobox 1 | [wortmannin co-treated with INS protein] inhibits the reaction [Glucose affects the localization of PDX1 protein] |
affects cotreatment
/ affects localization / decreases reaction |
protein |
11574405
|
C009687 | 3651 |
PDX1
GSF IDX-1 IPF1 IUF1 MODY4 PDX-1 STF-1 |
pancreatic and duodenal homeobox 1 | wortmannin inhibits the reaction [Glucose affects the localization of PDX1 protein] |
affects localization
/ decreases reaction |
protein |
11574405
|
C009687 | 5290 |
PIK3CA
CLOVE CWS5 MCAP MCM MCMTC PI3K p110-alpha |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) | wortmannin inhibits the reaction [Sirolimus results in increased activity of PIK3CA protein] |
decreases reaction
/ increases activity |
protein |
16227402
|
C009687 | 5290 |
PIK3CA
CLOVE CWS5 MCAP MCM MCMTC PI3K p110-alpha |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) | wortmannin results in decreased activity of PIK3CA protein |
decreases activity
|
protein |
19036708
|
C009687 | 5291 |
PIK3CB
P110BETA PI3K PI3KBETA PIK3C1 |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta (EC:2.7.1.153) | wortmannin results in decreased activity of PIK3CB protein |
decreases activity
|
protein |
11931710
|
C009687 | 5295 |
PIK3R1
AGM7 GRB1 p85 p85-ALPHA |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | wortmannin results in decreased activity of PIK3R1 protein |
decreases activity
|
protein |
19036708
|
C009687 | 10761 |
PLAC1
CT92 OOSP2L |
placenta-specific 1 | wortmannin inhibits the reaction [FGF7 protein results in increased expression of PLAC1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15803460
|
C009687 | 8493 |
PPM1D
PP2C-DELTA WIP1 |
protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16) | wortmannin inhibits the reaction [Soil Pollutants results in increased expression of PPM1D protein] |
decreases reaction
/ increases expression |
protein |
22409540
|
C009687 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | wortmannin inhibits the reaction [Curcumin results in increased phosphorylation of PRKCD protein] |
decreases reaction
/ increases phosphorylation |
protein |
17171638
|
C009687 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | wortmannin inhibits the reaction [Oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein] |
decreases reaction
/ increases activity / increases localization |
protein |
11424089
|
C009687 | 5728 |
PTEN
10q23del BZS CWS1 DEC GLM2 MHAM MMAC1 PTEN1 TEP1 |
phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) | wortmannin inhibits the reaction [PTEN protein results in increased susceptibility to Doxorubicin] |
decreases reaction
/ increases response to substance |
protein |
17935137
|
C009687 | 5728 |
PTEN
10q23del BZS CWS1 DEC GLM2 MHAM MMAC1 PTEN1 TEP1 |
phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) | wortmannin inhibits the reaction [PTEN protein results in increased susceptibility to Etoposide] |
decreases reaction
/ increases response to substance |
protein |
17935137
|
C009687 | 5731 |
PTGER1
EP1 |
prostaglandin E receptor 1 (subtype EP1), 42kDa | wortmannin inhibits the reaction [[Dinoprostone binds to and results in increased activity of PTGER1 protein] which results in increased expression of HIF1A protein] |
affects binding
/ decreases reaction / increases activity / increases expression |
protein |
20335389
|
C009687 | 5731 |
PTGER1
EP1 |
prostaglandin E receptor 1 (subtype EP1), 42kDa | wortmannin inhibits the reaction [[Dinoprostone binds to and results in increased activity of PTGER1 protein] which results in increased phosphorylation of RPS6 protein] |
affects binding
/ decreases reaction / increases activity / increases phosphorylation |
protein |
20335389
|
C009687 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | wortmannin inhibits the reaction [PTGS2 protein results in decreased susceptibility to Carboplatin] |
decreases reaction
/ decreases response to substance |
protein |
18089846
|
C009687 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | wortmannin inhibits the reaction [Zinc results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15980035
|
C009687 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | wortmannin inhibits the reaction [Zinc results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
15980035
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with oxophenylarsine] results in increased phosphorylation of PTK2 protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | Atropine inhibits the reaction [oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation / increases reaction |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | oxotremorine M inhibits the reaction [[wortmannin co-treated with oxophenylarsine] results in increased phosphorylation of PTK2 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein] |
affects cotreatment
/ increases phosphorylation / increases reaction |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | [Pilocarpine co-treated with wortmannin] results in increased phosphorylation of PTK2 protein |
affects cotreatment
/ increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | [Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein |
affects cotreatment
/ increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | [wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein |
affects cotreatment
/ increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | [wortmannin co-treated with oxophenylarsine] results in increased phosphorylation of PTK2 protein |
affects cotreatment
/ increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | [wortmannin co-treated with Tetradecanoylphorbol Acetate] inhibits the reaction [oxotremorine M results in increased phosphorylation of PTK2 protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | wortmannin inhibits the reaction [Testosterone results in increased phosphorylation of PTK2 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16038899
|
C009687 | 5829 |
PXN
|
paxillin | Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5829 |
PXN
|
paxillin | [oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein] |
affects cotreatment
/ decreases reaction / increases phosphorylation |
protein |
10537051
|
C009687 | 5829 |
PXN
|
paxillin | wortmannin inhibits the reaction [oxotremorine M results in increased phosphorylation of PXN protein] |
decreases reaction
/ increases phosphorylation |
protein |
10537051
|
C009687 | 5887 |
RAD23B
HHR23B HR23B P58 |
RAD23 homolog B (S. cerevisiae) | wortmannin inhibits the reaction [Cisplatin results in increased expression of RAD23B protein] |
decreases reaction
/ increases expression |
protein |
21742020
|
C009687 | 10111 |
RAD50
NBSLD RAD502 hRad50 |
RAD50 homolog (S. cerevisiae) | [wortmannin co-treated with docetaxel] results in decreased expression of RAD50 protein |
affects cotreatment
/ decreases expression |
protein |
20878124
|
C009687 | 5906 |
RAP1A
KREV-1 KREV1 RAP1 SMGP21 |
RAP1A, member of RAS oncogene family | wortmannin inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein] |
decreases reaction
/ increases activity |
protein |
16963453
|
C009687 | 6194 |
RPS6
S6 |
ribosomal protein S6 | wortmannin inhibits the reaction [[Dinoprostone binds to and results in increased activity of PTGER1 protein] which results in increased phosphorylation of RPS6 protein] |
affects binding
/ decreases reaction / increases activity / increases phosphorylation |
protein |
20335389
|
C009687 | 6199 |
RPS6KB2
KLS P70-beta P70-beta-1 P70-beta-2 S6K-beta2 S6K2 SRK STK14B p70(S6K)-beta p70S6Kb |
ribosomal protein S6 kinase, 70kDa, polypeptide 2 (EC:2.7.11.1) | wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein] |
decreases reaction
/ increases activity |
protein |
12087098
|
C009687 | 7857 |
SCG2
CHGC EM66 SN SgII |
secretogranin II | wortmannin results in decreased activity of SCG2 protein alternative form |
decreases activity
|
protein |
9473216
|
C009687 | 871 |
SERPINH1
AsTP3 CBP1 CBP2 HSP47 OI10 PPROM RA-A47 SERPINH2 gp46 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | wortmannin inhibits the reaction [cobaltous chloride results in decreased expression of SERPINH1 mRNA] |
decreases expression
/ decreases reaction |
mRNA |
13679210
|
C009687 | 871 |
SERPINH1
AsTP3 CBP1 CBP2 HSP47 OI10 PPROM RA-A47 SERPINH2 gp46 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | wortmannin inhibits the reaction [cobaltous chloride results in decreased expression of SERPINH1 protein] |
decreases expression
/ decreases reaction |
protein |
13679210
|
C009687 | 140885 |
SIRPA
BIT CD172A MFR MYD-1 P84 PTPNS1 SHPS1 SIRP |
signal-regulatory protein alpha (EC:3.1.3.48) | wortmannin inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] |
decreases reaction
/ increases secretion |
protein |
12805067
|
C009687 | 23411 |
SIRT1
SIR2L1 |
sirtuin 1 | wortmannin promotes the reaction [arsenic disulfide results in decreased expression of SIRT1 protein] |
decreases expression
/ increases reaction |
protein |
18298901
|
C009687 | 6528 |
SLC5A5
NIS TDH1 |
solute carrier family 5 (sodium/iodide cotransporter), member 5 | wortmannin inhibits the reaction [Carbamazepine promotes the reaction [Tretinoin results in increased expression of SLC5A5 protein]] |
decreases reaction
/ increases expression / increases reaction |
protein |
20300827
|
C009687 | 6531 |
SLC6A3
DAT DAT1 PKDYS |
solute carrier family 6 (neurotransmitter transporter), member 3 | wortmannin inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine] |
decreases reaction
/ increases uptake |
protein |
20875051
|
C009687 | 6667 |
SP1
|
Sp1 transcription factor | wortmannin inhibits the reaction [Etoposide results in increased phosphorylation of SP1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17441964
|
C009687 | 412 |
STS
ARSC ARSC1 ASC ES SSDD XLI |
steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) | wortmannin inhibits the reaction [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased activity of STS protein] |
decreases reaction
/ increases activity |
protein |
16178010
|
C009687 | 412 |
STS
ARSC ARSC1 ASC ES SSDD XLI |
steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) | wortmannin inhibits the reaction [AGN 195183 results in increased activity of STS protein] |
decreases reaction
/ increases activity |
protein |
16178010
|
C009687 | 412 |
STS
ARSC ARSC1 ASC ES SSDD XLI |
steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) | wortmannin inhibits the reaction [tazarotene results in increased activity of STS protein] |
decreases reaction
/ increases activity |
protein |
16178010
|
C009687 | 412 |
STS
ARSC ARSC1 ASC ES SSDD XLI |
steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) | wortmannin inhibits the reaction [Tretinoin results in increased activity of STS protein] |
decreases reaction
/ increases activity |
protein |
16178010
|
C009687 | 7077 |
TIMP2
CSC-21K DDC8 |
TIMP metallopeptidase inhibitor 2 | wortmannin inhibits the reaction [CYP4Z1 protein results in increased expression of TIMP2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22841774
|
C009687 | 7082 |
TJP1
ZO-1 |
tight junction protein 1 | wortmannin inhibits the reaction [telmisartan affects the localization of TJP1 protein] |
affects localization
/ decreases reaction |
protein |
19252288
|
C009687 | 7082 |
TJP1
ZO-1 |
tight junction protein 1 | wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA] |
decreases expression
/ decreases reaction |
mRNA |
19252288
|
C009687 | 7082 |
TJP1
ZO-1 |
tight junction protein 1 | wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 protein] |
decreases expression
/ decreases reaction |
protein |
19252288
|
C009687 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | wortmannin inhibits the reaction [Ciprofloxacin inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] |
affects cotreatment
/ decreases reaction / increases abundance |
protein |
16968468
|
C009687 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | wortmannin inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] |
decreases reaction
/ increases secretion |
protein |
12805067
|
C009687 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | wortmannin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22556157
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [2-chloroethyl ethyl sulfide results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19111594
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [3,3'-diindolylmethane results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22290291
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Asbestos, Serpentine results in increased expression of TP53 protein] |
decreases reaction
/ increases expression |
protein |
12676607
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
12676607
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15837074
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of TP53 protein]] |
decreases reaction
/ increases phosphorylation / increases reaction |
protein |
15489221
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Mustard Gas results in increased expression of TP53 protein] |
decreases reaction
/ increases expression |
protein |
22119920
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Mustard Gas results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22119920
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [Nitric Oxide results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16024610
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [resveratrol results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17534123
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin inhibits the reaction [spermine nitric oxide complex results in increased phosphorylation of TP53 protein] |
decreases reaction
/ increases phosphorylation |
protein |
16024610
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin promotes the reaction [arsenic disulfide results in increased expression of and results in increased phosphorylation of TP53 protein] |
increases expression
/ increases phosphorylation / increases reaction |
protein |
18298901
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin results in decreased phosphorylation of and results in decreased expression of TP53 protein |
decreases expression
/ decreases phosphorylation |
protein |
22290291
|
C009687 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | wortmannin results in decreased phosphorylation of TP53 protein |
decreases phosphorylation
|
protein |
22119920
|
C009687 | 7161 |
TP73
P73 |
tumor protein p73 | wortmannin promotes the reaction [Cisplatin results in increased expression of TP73 protein] |
increases expression
/ increases reaction |
protein |
21214929
|
C009687 | 7161 |
TP73
P73 |
tumor protein p73 | wortmannin promotes the reaction [Doxorubicin results in increased expression of TP73 protein] |
increases expression
/ increases reaction |
protein |
21214929
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [4-hydroxyestradiol results in increased expression of VEGFA protein] |
decreases reaction
/ increases expression |
protein |
15050414
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [4-tert-octylphenol results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
18252963
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [butylbenzyl phthalate results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
18252963
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [cobaltous chloride results in increased expression of VEGFA mRNA] |
decreases reaction
/ increases expression |
mRNA |
13679210
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [cobaltous chloride results in increased expression of VEGFA protein] |
decreases reaction
/ increases expression |
protein |
13679210
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [CYP4Z1 protein results in increased expression of VEGFA mRNA] |
decreases reaction
/ increases expression |
mRNA |
22841774
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [Dieldrin results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
18252963
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [Estradiol results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
18252963
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [Genistein results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
18252963
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [IGF1 protein results in increased secretion of VEGFA protein] |
decreases reaction
/ increases secretion |
protein |
16499871
|
C009687 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | wortmannin inhibits the reaction [oxaliplatin results in increased expression of VEGFA protein] |
decreases reaction
/ increases expression |
protein |
18790786
|
C009687 | 7520 |
XRCC5
KARP-1 KARP1 KU80 KUB2 Ku86 NFIV |
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | [wortmannin co-treated with docetaxel] results in decreased expression of XRCC5 protein |
affects cotreatment
/ decreases expression |
protein |
20878124
|
C009687 | 2547 |
XRCC6
CTC75 CTCBF G22P1 KU70 ML8 TLAA |
X-ray repair complementing defective repair in Chinese hamster cells 6 | [wortmannin co-treated with docetaxel] results in decreased expression of XRCC6 protein |
affects cotreatment
/ decreases expression |
protein |
20878124
|
C009687 | 10413 |
YAP1
YAP YAP2 YAP65 YKI |
Yes-associated protein 1 | wortmannin promotes the reaction [Cisplatin results in increased expression of YAP1 protein modified form] |
increases expression
/ increases reaction |
protein |
21214929
|
C009687 | 10413 |
YAP1
YAP YAP2 YAP65 YKI |
Yes-associated protein 1 | wortmannin promotes the reaction [Doxorubicin results in increased expression of YAP1 protein modified form] |
increases expression
/ increases reaction |
protein |
21214929
|
C009687 | 7702 |
ZNF143
SBF STAF pHZ-1 |
zinc finger protein 143 | wortmannin inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein] |
decreases reaction
/ increases expression |
protein |
20733350
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
#615214 | Agammaglobulinemia 7, autosomal recessive; agm7 |
P27986
|
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#114480 | Breast cancer |
O96017
P31749 P42336 |
#615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#192600 | Cardiomyopathy, familial hypertrophic, 1; cmh1 |
Q9H1R3
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#303600 | Coffin-lowry syndrome; cls |
P51812
|
#114500 | Colorectal cancer; crc |
P31749
P42336 P84022 Q14191 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P31751
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#612219 | Ewing sarcoma; es |
P11308
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P42336
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
#182000 | Keratosis, seborrheic |
P42336
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#609265 | Li-fraumeni syndrome 2; lfs2 |
O96017
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300844 | Mental retardation, x-linked 19; mrx19 |
P51812
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259500 | Osteogenic sarcoma |
O96017
|
#167000 | Ovarian cancer |
P42336
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#176807 | Prostate cancer |
O96017
|
#176920 | Proteus syndrome |
P31749
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#269880 | Short syndrome |
P27986
|
#243060 | Spermatogenic failure 5; spgf5 |
Q9UQB9
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00881 | Li-Fraumeni syndrome |
O96017
(related)
P04637 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
P31751 (related) P42336 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P51812
(related)
Q99714 (related) |
H00574 | Coffin-Lowry syndrome (CLS) |
P51812
(related)
|
H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H01282 | Spermatogenic failure |
Q9UQB9
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D000230 | C009687 | Adenocarcinoma |
therapeutic
|
23064031
|
|
D001943 | C009687 | Breast Neoplasms |
therapeutic
|
23064031
|
|
D005234 | C009687 | Fatty Liver |
marker/mechanism
|
22459179
|
|
D006930 | C009687 | Hyperalgesia |
therapeutic
|
16360265
17043245 |
|
D009336 | C009687 | Necrosis |
marker/mechanism
|
21410490
|
|
D009361 | C009687 | Neoplasm Invasiveness |
therapeutic
|
23064031
|
|
D009362 | C009687 | Neoplasm Metastasis |
therapeutic
|
23064031
|
|
D010051 | C009687 | Ovarian Neoplasms |
therapeutic
|
17404021
|
|
D010146 | C009687 | Pain |
therapeutic
|
17084039
|
|
D011041 | C009687 | Poisoning |
therapeutic
|
22155090
|
|
D013927 | C009687 | Thrombosis |
therapeutic
|
12606772
|